Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.

Frauke StascheitUlrike GrittnerSarah HoffmannPhilipp MergenthalerMichael SchroeterTobias RuckMark PawlitzkiFranz BlaesJulia KaiserUlrike ScharaAdela Della-MarinaAndrea ThiemeTim HagenackerChristian JacobiBenjamin BergerPeter P UrbanKarl Christian KnopBerthold SchalkeDe-Hyung LeePetra KalischewskiHeinz WiendlAndreas Meisel

Published in: Journal of neurology (2022)

German clinical trial registry ( https://www.drks.de ), DRKS00024099, first patient enrolled: February 4th, 2019.

Keyphrases

myasthenia gravis
clinical trial
coronavirus disease
sars cov
case report
phase ii
open label
study protocol
double blind
respiratory syndrome coronavirus
placebo controlled